Literature DB >> 1593719

Erectile dysfunction due to atherosclerotic vascular disease: the development of an animal model.

K M Azadzoi1, I Goldstein.   

Abstract

An animal model was developed to study the pathophysiology of erectile dysfunction due to atherosclerotic vascular disease. Thirty one New Zealand white male rabbits were divided into control (n = 5) and treatment groups (n = 26). The control group was placed on a regular diet while the treatment group underwent balloon de-endothelialization of the aorto-iliac arteries and received 1.6% cholesterol and 4% triglyceride diet for eight weeks. After eight weeks in the control animals (n = 5), blood levels of cholesterol, triglycerides and low density lipoproteins, radiologic studies as well as hemodynamic parameters of erectile function were all normal. In the surviving treatment animals (n = 21) after the same time period, a significant increase in blood levels of cholesterol, triglyceride and low density lipoprotein were observed. In addition, 62% of these animals developed hypertension which was not observed in the control group. Angiographically, 10 animals (48%) demonstrated severe atherosclerotic lesions (75% to 100% occlusion of common or internal iliac arteries on one side and over 50% occlusion of the opposite side), five (24%) had moderate lesions (50 to 75% luminal occlusion of right and left common iliac or internal iliac arteries) and 6 revealed minimal lesions (less than 50% occlusion of the right and left common iliac or internal iliac arteries). Of the 15 animals with 50% or greater luminal occlusion of the iliohypogastric arteries, erectile dysfunction was found in 93% of cases. Due to the development of erectile dysfunction in 33% of animals with minimal occlusive lesions, it appears that factors, other than large vessel luminal occlusion, may exist in this animal model which adversely influence erectile function. This model may therefore be of further benefit in the study of other factors associated with atherosclerosis and impotence, such as the possible concomitant hypercholesterolemic and atherosclerotic-induced alterations in the local reactivity of corpus cavernosum smooth muscle and lacunar space endothelial cells.

Entities:  

Mesh:

Year:  1992        PMID: 1593719     DOI: 10.1016/s0022-5347(17)37676-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  Erectile dysfunction and atherosclerosis.

Authors:  Robert A Kloner; Mark Speakman
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

2.  Evaluation of arterial stiffness and cardiac function in patients with vascular erectile dysfunction: acute effects of phosphodiesterase-5 inhibitor tadalafil.

Authors:  O Özdabakoğlu; S Güllülü; S Sağ; T Şentürk; H Kiliçarslan; A Tütüncü; M Keçebaş; I Baran; A Aydinlar
Journal:  Int J Impot Res       Date:  2016-12-08       Impact factor: 2.896

3.  Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil.

Authors:  Serap Gur; Suresh C Sikka; Gillian E Knight; Geoffrey Burnstock; Wayne J G Hellstrom
Journal:  Asian J Androl       Date:  2010-03-22       Impact factor: 3.285

4.  What is the best predictor of postoperative erectile function in patients who will undergo coronary artery bypass surgery?

Authors:  Fatih Hizli; Burak Işler; Zeki Güneş; M Ali Ozatik; Ferhat Berkmen
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.370

5.  The Comparison of the Effects of Nebivolol and Metoprolol on Erectile Dysfunction in the Cases with Coronary Artery Bypass Surgery.

Authors:  Özcan Gür; Selami Gurkan; Gunduz Yumun; Polat Turker
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-03-10       Impact factor: 1.520

6.  Scrutiny of cardiovascular risk factors by assessing arterial stiffness in erectile dysfunction patients.

Authors:  Shih-Tai Chang; Chi-Ming Chu; Jen-Te Hsu; Chang-Min Chung; Kuo-Li Pan; Ju-Feng Hsiao; Yu-Sheng Lin
Journal:  World J Urol       Date:  2009-11-05       Impact factor: 4.226

7.  Diagnostic value of radionuclide phallography with intravenous vasodilator stress in the evaluation of arteriogenic impotence.

Authors:  Q H Siraj; A J Hilson
Journal:  Eur J Nucl Med       Date:  1994-07

8.  Prevalence of erectile dysfunction in chronic renal disease patients on conservative treatment.

Authors:  José Fernando Pereira Mesquita; Thiago Faria Ramos; Felipe Pereira Mesquita; José Murillo Bastos Netto; Marcus Gomes Bastos; André Avarese de Figueiredo
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

9.  Endothelial dysfunction, erectile dysfunction and phosphodiesterase 5 inhibitors. An update of the current data and future perspectives.

Authors:  Angelis Konstantinopoulos; Konstantinos Giannitsas; Spiros Raptis; Petros Perimenis
Journal:  Drug Target Insights       Date:  2007-05-29

10.  Association between Fragmented QRS and Left Ventricular Systolic Function in Patients with Erectile Dysfunction.

Authors:  Osman Bektaş; Ahmet Karagöz; Adil Bayramoğlu; Erdal Benli; Zeki Yüksel Günaydın; Mehmet Yaman; Ahmet Kaya
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.